Screening for primary aldosteronism in 1,181 Swedish primary care patients with hypertension
ObjectivePrimary aldosteronism (PA) is a common cause of hypertension. It entails elevated morbidity and mortality that do not sufficiently improve with conventional antihypertensive therapy. Screening for PA by plasma aldosterone–renin ratio (ARR) enables discovery and specific treatment of affecte...
Saved in:
| Main Authors: | Nikita Makhnov, Jakob Skov, Tobias Åkerström, Fredrik Axling, Daniel Andernord, Mikael Bergenheim, Mauritz Waldén, Per Hellman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1555572/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum microRNAs as peripheral markers of primary aldosteronism
by: Nikita Makhnov, et al.
Published: (2025-03-01) -
Effect of Age on Aldosterone–Renin Ratio in Screening Primary Aldosteronism
by: Ning Peng, et al.
Published: (2025-03-01) -
Comparison between screening for primary aldosteronism with and without drug adjustment
by: Yanlong Hua, et al.
Published: (2024-12-01) -
Effect of plasma aldosterone concentration on serum uric acid metabolism
by: WEI Yushuang, et al.
Published: (2025-02-01) -
Duration of rheumatoid arthritis changes blood levels of angiotensin and aldosterone
by: Boris A. Rebrov, et al.
Published: (2023-12-01)